BeiGene's datuximab beta injections and injectable zenidazumab entered the first edition of the commercial insurance innovative drug catalogue.

Zhitongcaijing · 12/07/2025 03:25
BeiGene's datuximab beta injections and injectable zenidazumab entered the first edition of the commercial insurance innovative drug catalogue.